243 related articles for article (PubMed ID: 9314014)
1. alpha-Glucosidase inhibitors.
Lebovitz HE
Endocrinol Metab Clin North Am; 1997 Sep; 26(3):539-51. PubMed ID: 9314014
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Yamada K
Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
[TBL] [Abstract][Full Text] [Related]
3. [Postprandial hyperglycemia. II. Pharmacological approaches].
Scheen AJ; Letiexhe MR; Geronooz I; Paquot N; Jandrain B
Rev Med Liege; 2002 Apr; 57(4):196-201. PubMed ID: 12073790
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy with insulin and alpha-glucosidase inhibitor].
Watanabe K; Kawamori R
Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
[No Abstract] [Full Text] [Related]
5. New horizons in diabetes therapy--alpha glucosidase inhibitors.
Jawad F
J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
[No Abstract] [Full Text] [Related]
6. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
Gendeleka GF
Lik Sprava; 1997; (6):105-7. PubMed ID: 9589946
[TBL] [Abstract][Full Text] [Related]
7. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
Odaka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024
[No Abstract] [Full Text] [Related]
8. The evolving role of alpha-glucosidase inhibitors.
Göke B; Herrmann-Rinke C
Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S31-8. PubMed ID: 9816485
[No Abstract] [Full Text] [Related]
9. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Nakamura J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
[No Abstract] [Full Text] [Related]
10. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors].
Blicklé JF; Andres E; Brogard JM
Rev Med Interne; 1999 Aug; 20 Suppl 3():379s-383s. PubMed ID: 10480189
[TBL] [Abstract][Full Text] [Related]
11. Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.
Rabasa-Lhoret R; Chiasson JL
Drugs Aging; 1998 Aug; 13(2):131-43. PubMed ID: 9739502
[TBL] [Abstract][Full Text] [Related]
12. Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update.
Usman B; Sharma N; Satija S; Mehta M; Vyas M; Khatik GL; Khurana N; Hansbro PM; Williams K; Dua K
Curr Pharm Des; 2019; 25(23):2510-2525. PubMed ID: 31333110
[TBL] [Abstract][Full Text] [Related]
13. [Combined therapy with insulin and alpha-glucosidase inhibitor].
Watanabe K; Kawamori R
Nihon Rinsho; 1997 Nov; 55 Suppl():261-6. PubMed ID: 9434478
[No Abstract] [Full Text] [Related]
14. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Sakamoto N; Tajima N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
[No Abstract] [Full Text] [Related]
15. Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.
Yamazaki K; Inoue T; Yasuda N; Sato Y; Nagakura T; Takenaka O; Clark R; Saeki T; Tanaka I
J Pharmacol Sci; 2007 May; 104(1):29-38. PubMed ID: 17485917
[TBL] [Abstract][Full Text] [Related]
16. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
17. Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Hedrington MS; Davis SN
Expert Opin Pharmacother; 2019 Dec; 20(18):2229-2235. PubMed ID: 31593486
[No Abstract] [Full Text] [Related]
18. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
Joshi SR; Standl E; Tong N; Shah P; Kalra S; Rathod R
Expert Opin Pharmacother; 2015; 16(13):1959-81. PubMed ID: 26255950
[TBL] [Abstract][Full Text] [Related]
19. Effects of beano on the tolerability and pharmacodynamics of acarbose.
Lettieri JT; Dain B
Clin Ther; 1998; 20(3):497-504. PubMed ID: 9663365
[TBL] [Abstract][Full Text] [Related]
20. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.
van de Laar FA
Vasc Health Risk Manag; 2008; 4(6):1189-95. PubMed ID: 19337532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
